Skip to main content

Table 2 Characteristics of studies involving in comparison of the differences of serum Cys C levels

From: The association between cystatin C and COPD: a meta-analysis and systematic review

Author

Year

SCOPD

AECOPD

Control

n1

Mean1

SD1

n2

Mean2

SD2

n3

Mean3

SD3

Qu et al [37]

2010

70

1.76

0.62

/

/

/

30

0.98

0.51

Sun et al [39]

2013

30

0.95

0.23

54

1.12

0.26

/

/

/

Zhang et al [27]

2014

129

0.115

0.05

/

/

/

122

0.105

0.03

Zhang et al [29]

2014

299

1.03

0.21

93

1.09

0.22

151

0.84

0.18

Yoshizawa et al [40]

2015

108

1.2

0.4

/

/

/

73

0.9

0.2

Liu et al [41]

2015

60

0.1254

0.0309

72

0.1315

0.0425

36

0.1084

0.0267

Zhang et al [42]

2015

/

/

/

90

1.31

0.3

90

0.87

0.13

Zhou et al [43]

2016

60

0.94

0.22

108

1.13

0.25

/

/

/

Ni et al [44]

2017

45

0.1339

0.0154

45

0.1478

0.0212

45

0.1045

0.0209

Selda et al [31]

2018

68

1.01

0.56

58

0.97

0.29

50

0.47

0.13

Amado et al [28]

2018

65

0.97

0.32

/

/

/

18

0.88

0.2

Dickson et al [30]

2019

362

1.18

0.471

1637

1.21

0.47

/

/

/

  1. Abbreviations: COPD Chronic obstructive pulmonary disease, Cys C Cystatin C, AECOPD acute exacerbation COPD, SCOPD stable COPD